|
|
| |
| Most Discussed Stocks |
 |
|
|
|
| |
|
News |
| |
|
WILL THE FDA GIVE THE GREEN LIGHT T.... |
10/06/2008 |
|
Has the time come for Provenge, the prostate cancer vaccine developed by Dendreon, to be given marketing approval so it can save condemned metastatic prostate cancer patients’ lives? |
| |
|
PROGENICS: THE HIV DRUG LOOKS PROMI.... |
10/02/2008 |
|
|
| |
|
WE WILL BE ALL RIGHT |
09/25/2008 |
|
We gave you Sequenom and many other winners. Prohost will continue to do the same, hopefully without as much struggling against the greed of those who took advantage of the market deregulation to turn it into a vehicle for self-fulfillment of destructive prophesies at the expense of the serious investors.
We surely believe that America is capable of overcoming this crisis. Yet, our hope is in a reform that stops the greed that tarnished the market’s and America’s strong economy’s reputation.
We will be all right.
|
| |
|
SEQUENOM (SQNM): SUCCESS OF NON INV.... |
09/24/2008 |
|
The results are 100% without manipulation of the fetus and with a simple mother\'s blood test. |
| |
|
CYTRX COMPLETES ITS BUYOUT OF INNOV.... |
09/23/2008 |
|
Cytrx inherited the cancer drug tamibarotene, which has been approved in Japan for acute promyelocytic leukemia (APL). It also inherited three other drug candidates. Read about tamibarotene. Read also about the a stool test that shows successful results in diagnosing colorectal cancer. |
| |
|
|
| |
| |
| |
|
|
Stocks >> Stocks Details |
|
AFFX
|
| |
|
ANALYZING THE RELATIONSHIP BETWEEN GENETICS AND HEALTH |
|
|
|
AFFYMETRIX
|
| |
|
AFFYMETRIX (AFFX): The firm’s scientists invented the world's first
microarray in 1989 and began selling the first commercial microarray in 1994.
Since then,
Affymetrix GeneChip® has become the industry standard and is used by pharmaceutical,
diagnostic and biotechnology companies, research institutes, governments and
not-for-profit research institutes.
Thousands of systems have been shipped
around the world and over 3,000 peer-reviewed papers have been published using
the technology.
Affymetrix' patented photolithographic manufacturing process provides
the most information capacity available today on an array, enabling researchers
to use a whole-genome approach to analyze the relationship between genetics and
health.
Affimetrix is headquartered in Santa Clara, California with
subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento,
California and Bedford, Massachusetts. Web: www.affymetrix.com
|
| |
| |
| |
| |
| |
| |
|
|
|
|
